Rodger Novak, President at CRISPR Therapeutics AG (CRSP), sold 25,000 shares at $100.00 ($2.5M) on 2020-10-08, disclosed to the SEC on 2020-10-13.
Open-market sale of $2.5M CRSP by President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.00 | 22,238 | $2.2M | 89.0% |
| 2 | $100.00 | 2,762 | $276K | 11.0% |
| Total | $100.00 avg | 25,000 | $2.5M | 100% |
| Filing → |
| CRSP | SELL | 2021-06-23 | $6.4M | — | Filing → |
| CRSP | SELL | 2020-12-02 | $6.3M | — | Filing → |
| CRSP | SELL | 2020-09-03 | $4.6M | — | Filing → |